PAR-24-208 - NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Expired NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening | NOT-OD-22-179 | ODP, NIA, NIAAA, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIMH, NIMHD, NINDS, NINR, ODS, ORWH | Jul 14, 2022 | May 8, 2025 | R21, R01, R61/R33, UG3/UH3, R34, U01 |
| Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening | NOT-OD-22-107 | ODP, NIA, NIAAA, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIMH, NIMHD, NINDS, NINR, ODS, ORWH | May 12, 2022 | May 8, 2025 | 333, R01, R34, R21, R61/R33, U01, UG3/UH3 |
For technical issues E-mail OER Webmaster